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ABSTRACT Platelet-derived growth factor (PDGF) initiates
replication of density-arrested BALB/c-3T3 mouse cells by ren-
dering them "competent" to respond to factors contained in
plasma. Treatment of quiescent cells with PDGF rapidly. stimu-
lates the preferential synthesis of several cytoplasmic proteins
(molecular weights 29,000 to 70,000). Four oftheseproteins were
noted within 1.5 hr ofPDGF addition and one (pI) within 40 min.
Inhibitors of RNA synthesis prevented the synthesis of these pro-
teins. Both the synthesis ofpl and the stimulation ofDNA synthesis
displayed a similar dose response to PDGF concentration. Pitu-
itary fibroblast growth factor, which also induces competence,
stimulated pI and pH synthesis. Plasma, epidermal growth factor,
or insulin, which do not induce competence, did.not stimulate se-
lective synthesis ofthese proteins. A transformed variantofBALB/
c-3T3 cells, which has retained the growth requirement for plasma
factors but lost the requirement for PDGF, synthesizes these
PDGF-modulated proteins constitutively.
The platelet-derived growth factor (PDGF) (1, 2) is a heat-stable
cationic polypeptide which has been purified to homogeneity
(3, 4). It induces the first event in the. growth response of den-
sity-arrested BALB/c-3T3 mouse cells by rendering them
"competent" to respond to a second set of growth factors con-
tained in platelet-poor plasma (PPP) (5-6). Competence persists
for many hours after PDGF removal (5-6); subsequent addition
of plasma causes the cells to progress through GJG1 and into
S phase of growth. Plasma can be replaced by two growth fac-
tors: epidermal growth factor (EGF) and somatomedin (or in-
sulin) (7, 8). Although PDGF, EGF, or somatomedin alone in-
duces a weak growth response in our BALB/c-3T3 cells, in
combination they function synergistically (at 1 nM) to stimulate
the majority of cells to synthesize DNA.
Some information is available regarding the action of EGF
and somatomedins. Although binding and internalization occur
rapidly (9-11), continuous treatment is required for DNA syn-
thesis (9, 12). The growth-stimulatory action of these factors on
PDGF-treated BALB/c-3T3 cells or a human glial cell line may
be related to nutrient supply (13, 14).
Little is known regarding the action ofPDGF. This hormone
induces a pleotypic response but nutrients are not required for
its action (13). It appears to regulate cellular receptors for EGF
and somatomedin (11, 15). PDGF may have a different mech-
anism of action than other growth factors because a brief treat-
ment is sufficient to induce a growth response (5, 16). Fur-
thermore, unlike EGF or insulin, it causes transient centriole
deciliation in density-arrested BALB/c-3T3 cells (17).
Because little is known about PDGF function, our labora-
tories have examined the early molecular events in the growth
response. In a companion article (18), 'Smith and Stiles dem-
onstrate that competence can be transferred from' PDGF-
treated donor BALB/c-3T3 cells (or their cytoplasts) to un-
treated recipients by using fusion techniques. Treatment of
donors with inhibitors of RNA synthesis prevents acquisition
of this cytoplasmic signal. We now show that'PDGF selectively
promotes rapid synthesis of a family of cytoplasmic proteins
within quiescent BALB/c-3T3 cells; this response is blocked by
inhibitors of RNA synthesis..A functional association between
these proteins and the.PDGF-induced competent state is fur-
ther documented by several observations, including the con-
stitutive synthesis ofthe proteins by a variant BALB/c-3T3 cell
line that does not require PDGF for growth.
MATERIALS AND METHODS
BALB/c-3T3 (clone A31) or ST3T3 (clone 2) cells were grown
in Dulbecco's modified Eagle's medium (DME medium) (5).
Experiments were done on confluent cells 34 days after a me-
dium change. Confluent cells were transferred to incorporation
medium (DME medium containing 2.5% of the usual methio-
nine concentration) with or without purified growth factors or
plasma; at varioustimes, 30-50 uCi of [35S]methionine (Amer-
sham) per ml was added for 10-20 min (1 Ci = 3.7 x 1010
becquerels). The cells were washed, removed with a rubber
policeman, collected by centrifugation, and suspended in 100
,.d6ofreticulocyte saline buffer (0.01 M NaCVO.01 M Tris-HCV
.1.5,mM MgCl2 pH 7.4) containing 1% Nonidet P-40 (Sigma);
nuclei were removed by centrifugation. PDGF-modulated pro-
teins (termed cytoplasmic proteins) were found in -the nonnu-
clear fraction containing cytoplasm and membranes.
NaDodSO4 and 2-mercaptoethanol were each added to 1% and
samples were heated to 100'C. The quantity of ["5S]methionine
incorporated into trichloroacetic acid-precipitable material was
determined and equal quantities ofincorporated [35S]methionine
(usually 20,000 cpm) from these fractions were applied to poly-
acrylamide gels (19). After electrophoresis, gels were processed
forfluorography (20). Autoradiograms ofgels were scanned with
a densitometer and the density of protein bands was deter-
mined. Two-dimensional gel electrophoresis of cytoplasmic
fractions was performed by a modification ofthe described tech-
nique (21).
Most experiments were done with "partially purified PDGF,"
purified 500-fold by heat treatment and CM-Sephadex chro-
matography (3). "Highly purffied PDGF" was obtained by fur-
ther chromatography on Bio-Gel P150 (Bio-Rad) (3). Electro-
phoretically homogeneous PDGF was prepared by a modification
Abbreviations: DRB, 5,6-dichloro-3-D-ribofuranosylbenzimidazole;
DME medium, Dulbecco's modified Eagle's medium; EGF, epidermal
growth factor; FGF, pituitary fibroblast growth factor; PDGF, platelet-
derived growth factor; PPP, platelet-poor plasma.
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of published procedures (3). Pituitary fibroblast growth factor
(FGF) (22), EGF (23) (Collaborative Research, Waltham, MA),
insulin (Sigma), and PPP (American Red Cross) (5) were also
used. Actinomycin D, 5,6-dichloro-,-D-ribofuranosylbenzim-
idazole (DRB) (Sigma), and camptothecin (a gift of P. Vilk) were
used to inhibit RNA synthesis.
RESULTS
PDGF Stimulates Rapid Selective Synthesis of Proteins.
Density-inhibited BALB/c-3T3 cells were transferred to incor-
poration medium prewarmed to 37C. Some cultures were
treated with partially purified PDGF, and others with plasma
for 1.5-4.5 hr; [3S]methionine was then added. Twenty min-
utes later the cytoplasmic fractions were harvested, analyzed
on a 6-18% exponential gradient of polyacrylamide, and pro-
cessed for fluorography. Treatment with plasma for 1.5 hr did
not stimulate selective protein synthesis compared to medium
alone. PDGF induced preferential accumulation of four pro-
teins within this time (Fig. 1); a fifth was detectable within
3.0-4.5 hr. Molecular weights of these proteins were approxi-
mated as: pI, 29,000; pII, 35,000; pIII, 45,000; PIV, 60,000, and
pV, 70,000.
Accumulation of pI was studied in detail. Density-inhibited
cells were treated with partially purified PDGF for 20-0 min
and the newly synthesized proteins were analyzed on a 15%
polyacrylamide gel. Preferential accumulation of pI was de-
tected within 40 min (Fig. 2).
To learn if the PDGF-modulated proteins appear as a result
of degradation, [3S]methionine was added to quiescent cells
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FIG. 2. PDGF stimulates preferential synthesis of pI within 40
min. Density-arrested cells were treated with partially purified PDGF
(PF) at 25 jg/ml or5% PPP for-theindicated times prior to the addition
of[3Slmethionine. Ten minutes later the cultures were harvested. The




I, .4 , FM-
67
.







~ ~ ~ ~ ~ ~
'0 4LM. 4*
13-
DME PPP I-F PPP PF PPP PF
FIG. 1. PDGF stimulates selective synthesis of five cytoplasmic
proteins. Density-inhibited BALB/c-3T3 cells were transferred to in-
corporation medium alone (DME) or medium supplemented with
either dialyzed PPP at 5% or jartially purified PDGF (PF) at 25 Atg/
ml. At the indicated times, [ Slmethionine was added, and 20 min
later the cultures were harvested for gel electrophoresis. The arrows
indicate proteins that were preferentially synthesized in response to
PDGF. The positions of molecular weight markers are shown.
in medium containing a low concentration of plasma (0.25%).
The cells were washed and transferred to medium containing
no [3S]methionine and a 40-fold excess- of unlabeled methio-
nine. Treatment of these cultures with partially purified PDGF
(25 pug/ml) for 2 hr after transfer to [ S]methionine-free me-
dium did not increase the amounts of labeled pI or p1l; treat-
ment with an optimal concentration of plasma (5%) did not de-
crease them (data not shown). These proteins do not accumulate
as a result ofmodification ofproteins synthesized in the absence
of PDGF.
Two-dimensional gel electrophoresis ofcytoplasmic proteins
indicated that p1 is a single protein (Fig. 3). The density of the
pI spot from the PDGF-treated cultures appeared to be at least
10-fold greater than that of plasma-treated cultures. Although
pI was predominant, several other proteins were also prefer-
entially synthesized after PDGF treatment.
RNA Synthesis Requirement. Some cultures of density-in-
hibited cells were treated with actinomycin D (5 Ag/ml) for 30
min to inhibit >95% of RNA synthesis; they were then trans-
ferred to incorporation-smedium supplemented with partially
purified PDGF. Other cultures received no actinomycin D;
they were simply transferred to incorporation medium contain-
ing PDGF or plasma. [35S]Methionine was added to the cultures
1.5-4.5 hr after addition of PDGF or plasma and the cellular
proteins were separated on a 15% acrylamide gel. In the' ab-
sence ofactinomycin D, partially purified PDGF stimulated the
preferential synthesis of pI and pII. In its presence, there was
no detectable increase in pI or p1l synthesis compared to
plasma-supplemented cultures (Fig. 4). Inhibition of pl, pIT,
and pV synthesis by actinomycin D was also demonstrated by
using two-dimensional gel electrophoresis to resolve cytoplas-
mic proteins (data not shown). Other inhibitors of RNA syn-
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FIG. 3. Two-dimensional gel electrophoresis of PDGF- or plasma-
treated cells. Density-inhibited cells were treated with either highly
purified PDGF at 12 jg/ml (A) or 5% PPP (B) for 2 hr prior to
[35S]methionine addition. Cultures were harvested 20 min later and
cytoplasmic contents (200,000 cpm per sample) were applied to a non-
equilibrium pH gradient two-dimensional gel electrophoresis system.
The position of pI is indicated.
thesis, including camptothecin (30 .ug/ml) or DRB (50 p.M), also
prevented selective synthesis ofthese proteins (data not shown).
Synthesis of these proteins in response to PDGF appears to
require RNA synthesis.
pI Synthesis and Competence. Quiescent cells were treated
with various concentrations of partially purified PDGF or with
5% PPP for 3 hr. Some cultures were labeled with [3S]methionine
for one-dimensional gel analysis of pI. Synthesis of pI was es-
timated by scanning the fluorograms with a densitometer. The
amount of pI synthesized was regulated by the PDGF concen-
FIG. 4. Actinomycin D inhibits PDGF-stimulated pI and pII syn-
thesis. Density-inhibited cells were treated with 25 ug/ml ofpartially
purified PDGF (+ and -) or 5% PPP for the indicated times prior to
addition of [35S]methionine. The cultures were harvested 20 min later.
Some PDGF-treated cultures (+) were incubated with actinomycin D
at 5 pg/ml for 30 min prior to growth factor addition, whereas other
PDGF-treated cultures (-) received no actinomycin D. Plasma-treated
cultures received no actinomycin D. The arrows indicate pI (lower) and
p11 (upper).
tration (Fig. 5). After PDGF was removed from duplicate cul-
tures, the cells were transferred to medium supplemented with
5% PPP and [3H]thymidine. The percentage of cells that syn-
thesized DNA (competent cells) was also affunction ofthe PDGF
concentration (Fig. 5). The dose response for DNA synthesis
was similar to that for pI synthesis.
Complementation analysis has been used to define the hor-
monal growth factors that induce competence. PDGF or pitu-
itary FGF induces competence but insulin, EGF, or plasma
does not (7). To learn if those growth factors that induce com-
petence stimulate selective synthesis ofpI, confluent cells were
treated with electrophoretically pure PDGF, FGF, EGF, in-
sulin, plasma, or medium alone for 3 hr. PDGF and FGF stim-
ulated a 4- to 7-fold increase in the synthesis ofboth pI and pII
as compared to plasma-treated cultures (Table 1). EGF (50 ng/
ml) stimulated a small increase in p1l (1.5-fold) and no increase
in pI synthesis. Higher concentration (>1 pig/ml) stimulated
a small increase in pI synthesis (data not shown). Similarly, in-
sulin had little effect. Only growth factors that induce BALB/
c-3T3 cells to become competent cause a large increase in the
synthesis of these proteins.
Constitutive Synthesis of PDGF-Modulated Proteins. To
provide further evidence that PDGF-modulated selective pro-
tein synthesis regulates competence, we studied a variant of
BALB/c-3T3 cells (termed ST3T3), which spontaneously be-
came transformed and lost the growth requirement for PDGF.
A full characterization of this cell line will be reported else-
where. Briefly, like BALB/c-3T3 cells, the ST3T3 cells become
arrested at confluence with a G1 DNA content when grown in
medium supplemented with 10% serum. However, ST3T3 cells
become arrested at a 6-fold higher density (30 x 104 cells per
cm2) than BALB/c-3T3 cells. Density-arrested ST3T3 cells can
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FIG. 5. PDGF concentration regulates both the synthesis ofpI and
the percentage of cells that synthesize DNA. Density-inhibited cells
were treated with various concentrations of partially purified PDGF
(PF) for 3 hr or with 5% PPP. One set of cultures was labeled with
[35S]methionine for 20 min; after electrophoresis, the synthesis of pI
was estimated with a densitometer. Synthesis of pI in the PDGF-
treated cultures (0) is plotted as percentage ofcontrol PPP-treated cul-
tures). After treatment with PDGF or PPP, a duplicate group of cul-
tures was transferred to medium containing the usual methionine con-
centration, supplemented with 5% PPP and [3Hlthymidine to determine
the percentage of cells entering the S phase. The plates were fixed 20
hr later and processed for autoradiography (.).
be stimulated to replicate by the addition of plasma-supple-
mented medium and enter the S phase after a 10-hr lag. The
percentage of cells that synthesize DNA is governed by the
plasma concentration. Addition ofPDGF or FGF, with or with-
out plasma, has little or no effect on the percentage of cells that
synthesize DNA. Density-arrested BALB/c-3T3 or ST3T3 cells
were treated for 3 hr with highly purified PDGF or with PPP.
PDGF-induced the increased synthesis oftwo proteins (pI, p1I)
by BALB/c-3T3 cells; pIl was particularly prominent. The
ST3T3 cells synthesized these same proteins in the plasma-sup-
plemented medium; treatment with PDGF did not increase the
amount synthesized (Fig. 6). The relative amount of these pro-
teins synthesized by plasma-treated ST3T3 cells was equal to
or greater than that synthesized by PDGF-treated BALB/c-3T3
cells. It appears that ST3T3 cells synthesize these PDGF-mod-
ulated proteins constitutively.










Density-inhibited BALB/c-3T3 cells were treated with pure PDGF
(16 ng/ml), FGF (50 ng/ml), EGF (50 ng/ml), insulin (6 ,ug/ml), no
growth factor, orPPP (5%) for 3 hr andthen labeledwith [35s]methionine
for 20 min for electrophoresis. The density ofpI and pI was determined
with a densitometer and is given as the percent ofthe plasma controls.
This table is a composite of several experiments, each of which had a
















FIG. 6. Constitutive synthesis of PDGF-modulated proteins by
ST3T3 cells. BALB/c-3T3 cells and ST3T3 cells were grown to conflu-
ence in medium supplemented with 10% serum. Three days after the
last medium change, the density-arrested cultures were transferred
to incorporation medium supplemented with either 30% or 5% PPP or
highly purified PDGF at 14 pg/ml for 3 hr. ['S]Methionine was added
and 20 min later the cultures were harvested. Equal amounts of tri-
chloroacetic acid-insoluble contents (20,000 cpm per sample) were ap-
plied to a gel. The arrows (from top to bottom) indicate the positions
of pIH (Mr 35,000) and pI (Mr 29,000).
DISCUSSION
Treatment with PDGF stimulates selective synthesis of several
cytoplasmic proteins in BALB/c-3T3 cells. This response is very
rapid and appears to be contingent upon cellularRNA synthesis.
Four independent lines of evidence point to a tight association
between the synthesis of these proteins and PDGF-induced
competence. First, the PDGF dose response for pI induction
is similar to that for DNA synthesis. Second, the time course
for pI synthesis is similar to that for acquisition of competence.
A brieftreatment with PDGF induces both competence (5) and
pI synthesis. Third, a functional analogue of PDGF (pituitary
FGF) (7) induces pI and pIH; plasma growth factors, EGF, or
insulin, which do not induce competence (7), do not induce the
synthesis of these proteins. Finally, a BALB/c-3T3 cell variant
that synthesizes p1 and p1I constitutively has lost the growth


















4362 Cell Biology: Pledger et al.
Previous studies have noted that serum-stimulated cultures
synthesize specific proteins prior to S phase (24-30); however,
our experiments differ in a fundamental way. In previous stud-
ies, synthesis of specific proteins was detected during growth
as cells progressed through GdJG1 towards S phase. Because
the cells were growing, it could not be determined if the pro-
teins were regulatory in nature or appeared as a result ofgrowth.
Growth does not appear to be required for the synthesis of pI
and pII, because PDGF-treated cells display only a weak
growth response in the absence of plasma.
Like other growth factors, PDGF and FGF (31) trigger a
rapid pleotypic response; components of this response include
increased potassium uptake (32) and increased protein synthe-
sis. However, unlike other growth factors, PDGF and FGF
stimulate the rapid selective synthesis of several cytoplasmic
proteins. Stimulation of pI is detected within 40 min ofPDGF
addition. In mouse fibroblasts, the delay between transcription
and appearance ofnew mRNA in the cytoplasm is about 20 min
(33). Thus, the delay between addition of PDGF and modula-
tion ofgenes controlling pI expression is no greater than 20 min,
and it may be less; time intervals between 20 and 40 min were
not examined in these studies. To our knowledge, a comparable
rapid response at the level of gene transcription has not been
described for other polypeptide hormones (34-37). Induction
of pI by PDGF is comparable to induction of the heat shock
proteins in Drosophila (38) in terms of kinetics.
A variant cell line appears to synthesize two of the PDGF-
modulated proteins in a constitutive fashion. These proteins
were identified by using one criterion, molecular weight as de-
termined by gel electrophoresis. Additional criteria will have
to be utilized to unequivocally demonstrate identity of the
PDGF-modulated and constitutively synthesized proteins.
The saturation density of BALB/c-3T3 is regulated, in part,
by the concentration ofPDGF (5), which in turn modulates the
selective synthesis of several proteins. These proteins might
have a role in mediating the response to PDGF; other growth
factors, such as EGF and insulin, would act in a different man-
ner. In support of this model, competence can be transferred
from PDGF-treated donor cells to untreated recipient cells by
using cell fusion (18). Furthermore, a variant cell line that syn-
thesizes these proteins in a constitutive fashion grows in the
absence of PDGF. This variant, which was initially recognized
because it is morphologically transformed, grows to a 6-fold
higher density than BALB/c-3T3 cells. It is tempting to spec-
ulate, as Sachs (39) has done, that constitutive synthesis of
PDGF-modulated proteins provides one mechanism for alter-
ing cellular growth.
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